| 1 | institucional productos anti infecciosos | | | | | | | 3 | 0.90% |
| 2 | empresas representadas cristalia ferring | | | | | | | 3 | 0.90% |
| 3 | representadas cristalia ferring pharmaceuticals | | | | | | | 3 | 0.90% |
| 4 | inyectable anestésicos local y | | | | | | | 3 | 0.90% |
| 5 | vitamina inyectable anestésicos local | | | | | | | 3 | 0.90% |
| 6 | cristalia ferring pharmaceuticals isispharma | | | | | | | 2 | 0.60% |
| 7 | plasma anestésicos relacionados urologÍa | | | | | | | 2 | 0.60% |
| 8 | anestésicos relacionados urologÍa agentes | | | | | | | 2 | 0.60% |
| 9 | relacionados urologÍa agentes vasoactivos | | | | | | | 2 | 0.60% |
| 10 | kedrion biopharma farmacovigilancia información | | | | | | | 2 | 0.60% |
| 11 | musculares obstetricia derivados de | | | | | | | 2 | 0.60% |
| 12 | biopharma farmacovigilancia información médica | | | | | | | 2 | 0.60% |
| 13 | farmacovigilancia información médica contacto | | | | | | | 2 | 0.60% |
| 14 | inglés institucional productos anti | | | | | | | 2 | 0.60% |
| 15 | … continued leer más | | | | | | | 2 | 0.60% |
| 16 | productos anti infecciosos dermocosmética | | | | | | | 2 | 0.60% |
| 17 | punta de su dedo | | | | | | | 2 | 0.60% |
| 18 | la punta de su | | | | | | | 2 | 0.60% |
| 19 | derivados de plasma anestésicos | | | | | | | 2 | 0.60% |
| 20 | en la punta de | | | | | | | 2 | 0.60% |
| 21 | relajantes musculares obstetricia derivados | | | | | | | 2 | 0.60% |
| 22 | anestésicos local y regional | | | | | | | 2 | 0.60% |
| 23 | endocrinología fertilidad gastroenterología anestésicos | | | | | | | 2 | 0.60% |
| 24 | generales vitamina inyectable anestésicos | | | | | | | 2 | 0.60% |
| 25 | activa endocrinología fertilidad gastroenterología | | | | | | | 2 | 0.60% |
| 26 | analgésicos mayores relajantes musculares | | | | | | | 2 | 0.60% |
| 27 | mayores relajantes musculares obstetricia | | | | | | | 2 | 0.60% |
| 28 | san pablo brasil como | | | | | | | 1 | 0.30% |
| 29 | pablo brasil como soporte | | | | | | | 1 | 0.30% |
| 30 | brasil como soporte científico | | | | | | | 1 | 0.30% |
| 31 | como soporte científico en | | | | | | | 1 | 0.30% |
| 32 | continued leer más rinque | | | | | | | 1 | 0.30% |
| 33 | científico en las áreas | | | | | | | 1 | 0.30% |
| 34 | de san pablo brasil | | | | | | | 1 | 0.30% |
| 35 | en las áreas de | | | | | | | 1 | 0.30% |
| 36 | anestesia dolor y … | | | | | | | 1 | 0.30% |
| 37 | dolor y … continued | | | | | | | 1 | 0.30% |
| 38 | y … continued leer | | | | | | | 1 | 0.30% |
| 39 | soporte científico en las | | | | | | | 1 | 0.30% |
| 40 | rinque pharma iniciÓ sus | | | | | | | 1 | 0.30% |